To include your compound in the COVID-19 Resource Center, submit it here.
BPUR proposed to sell 25 million shares in a follow-on underwritten by Dawson James Securities. If sold
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury